日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial

Ravulizumab治疗IgA肾病的疗效和安全性：一项II期随机双盲安慰剂对照试验

期刊:Journal of the American Society of Nephrology
影响因子:9.4
doi:10.1681/ASN.0000000534
Lafayette, Richard; Tumlin, James; Fenoglio, Roberta; Kaufeld, Jessica; Pérez Valdivia, Miguel Ángel; Wu, Mai-Szu; Susan Huang, Shih-Han; Alamartine, Eric; Kim, Sung Gyun; Yee, Min; Kateifides, Andreas; Rice, Kara; Garlo, Katherine; Barratt, Jonathan
IgA
发表日期：2025
文献求助 收藏

Authors' Reply: Complement Inhibition Therapy in IgA Nephropathy: Total or Selective Inhibition?

作者回复：IgA肾病中的补体抑制疗法：完全抑制还是选择性抑制？

期刊:Journal of the American Society of Nephrology
影响因子:9.4
doi:10.1681/ASN.0000000674
Barratt, Jonathan; Garlo, Katherine; Kateifides, Andreas; Lafayette, Richard
IgA
免疫/内分泌
发表日期：2025
文献求助 收藏

Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials

Ravulizumab治疗非典型溶血性尿毒综合征：两项3期临床试验2年疗效和安全性结果分析

期刊:Kidney Medicine
影响因子:3.4
doi:10.1016/j.xkme.2024.100855
Dixon, Bradley P; Kavanagh, David; Aris, Alvaro Domingo Madrid; Adams, Brigitte; Kang, Hee Gyung; Wang, Edward; Garlo, Katherine; Ogawa, Masayo; Amancha, Praveen; Chakravarty, Sourish; Heyne, Nils; Kim, Seong Heon; Cataland, Spero; Yoon, Sung-Soo; Miyakawa, Yoshitaka; Luque, Yosu; Muff-Luett, Melissa; Tanaka, Kazuki; Greenbaum, Larry A
发表日期：2024
文献求助 收藏

Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab

探索性预后生物标志物在非典型溶血性尿毒综合征 (aHUS) 成人患者中与补体介导的血栓性微血管病 (CM-TMA) 相关：一项 Ravulizumab III 期研究的分析

期刊:Molecular Diagnosis & Therapy
影响因子:4.4
doi:10.1007/s40291-022-00620-3
Cammett, Tobin J; Garlo, Katherine; Millman, Ellen E; Rice, Kara; Toste, Catherine M; Faas, Susan J
心血管
免疫/内分泌
发表日期：2023
文献求助 收藏

Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab

更正：成人非典型溶血性尿毒综合征 (aHUS) 中补体介导的血栓性微血管病 (CM-TMA) 的探索性预后生物标志物：Ravulizumab III 期研究分析

期刊:Molecular Diagnosis & Therapy
影响因子:4.4
doi:10.1007/s40291-023-00643-4
Cammett, Tobin J; Garlo, Katherine; Millman, Ellen E; Rice, Kara; Toste, Catherine M; Faas, Susan J
心血管
免疫/内分泌
发表日期：2023
文献求助 收藏

Atypical Hemolytic Uremic Syndrome Treated With Ravulizumab or Eculizumab: A Claims-Based Evaluation of Health Care Resource Utilization and Clinical Outcomes in the United States

使用拉武利珠单抗或依库珠单抗治疗非典型溶血性尿毒综合征：美国基于索赔数据的医疗资源利用和临床结果评估

期刊:Kidney Medicine
影响因子:3.4
doi:10.1016/j.xkme.2023.100683
Wang, Yan; Al-Dakkak, Imad; Garlo, Katherine; Ong, Moh-Lim; Tomazos, Ioannis; Mahajerin, Arash
发表日期：2023
文献求助 收藏

Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndrome

治疗偏好和生活质量影响：拉武利珠单抗与依库珠单抗治疗非典型溶血性尿毒综合征

期刊:Journal of Comparative Effectiveness Research
影响因子:2.5
doi:10.57264/cer-2023-0036
Mauch, Teri J; Chladek, Michael R; Cataland, Spero; Chaturvedi, Shruti; Dixon, Bradley P; Garlo, Katherine; Gasteyger, Christoph; Java, Anuja; Leguizamo, Jorge; Lloyd-Price, Lucy; Pham, Tan P; Symonds, Tara; Tomazos, Ioannis; Wang, Yan
发表日期：2023
文献求助 收藏

Long-Term Efficacy and Safety of the Long-Acting Complement C5 Inhibitor Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in Adults

长效补体C5抑制剂Ravulizumab治疗成人非典型溶血性尿毒综合征的长期疗效和安全性

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2021.03.884
Barbour, Thomas; Scully, Marie; Ariceta, Gema; Cataland, Spero; Garlo, Katherine; Heyne, Nils; Luque, Yosu; Menne, Jan; Miyakawa, Yoshitaka; Yoon, Sung-Soo; Kavanagh, David
免疫/内分泌
发表日期：2021
文献求助 收藏

Facing COVID-19 in Liberia: Adaptations of the Resilient and Responsive Health Systems Initiative

应对利比里亚的 COVID-19：韧性和响应型卫生系统倡议的调整

期刊:Annals of Global Health
影响因子:3.2
doi:10.5334/aogh.3245
Marsh, Regan H; Plyler, Chelsea; Miller, Mary; Klar, Robin; Adeiza, Mukhtar; Wachekwa, Ian; Koomson, Freda; Garlo, James Luke Jr; Kruah, Kebeh; Lake, Sodey C; Matte, Rita; Cook, Rebecca; Maweu, Daniel; Kerr, Lila; Ogbuagu, Onyema; Talbert-Slagle, Kristina; Dahn, Bernice
发表日期：2021
文献求助 收藏

Apixaban versus No Anticoagulation in Patients Undergoing Long-Term Dialysis with Incident Atrial Fibrillation

阿哌沙班与不进行抗凝治疗在长期透析合并新发房颤患者中的疗效比较

期刊:Clinical Journal of the American Society of Nephrology
影响因子:7.1
doi:10.2215/CJN.11650919
Mavrakanas, Thomas A; Garlo, Katherine; Charytan, David M
发表日期：2020
文献求助 收藏